Home > Boards > US OTC > Biotechs > Titan Pharmaceuticals Inc. (TTNP)

I actually just bought back in from when

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Zilla Member Profile
 
Followed By 71
Posts 4,264
Boards Moderated 0
Alias Born 09/26/09
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:11:06 PM
Titan Pharmaceuticals Reports Third Quarter 2019 Financial Results PR Newswire (US) - 11/14/2019 4:03:00 PM
Titan Pharmaceuticals To Release Third Quarter 2019 Financial Results On November 14 - Conference Call To Follow PR Newswire (US) - 11/7/2019 4:30:00 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 11/4/2019 6:03:29 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/22/2019 9:56:11 AM
Titan Pharmaceuticals To Present Two Posters On Probuphine® At The 10th American Conference On Pharmacometrics PR Newswire (US) - 10/22/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/18/2019 4:33:31 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/17/2019 1:19:14 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/17/2019 6:01:01 AM
Titan Pharmaceuticals Announces Pricing Of $9.0 Million Underwritten Public Offering PR Newswire (US) - 10/16/2019 9:20:00 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 10/11/2019 1:44:48 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 10/8/2019 5:29:00 PM
Titan Pharmaceuticals and Crossroads of Southern Nevada Announce Probuphine® Availability at Crossroads Rehabilitation Facil... PR Newswire (US) - 10/1/2019 8:00:00 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 9/30/2019 6:02:47 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/20/2019 11:30:58 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 9/20/2019 9:46:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/18/2019 5:30:49 PM
Titan Receives Approval For Second Year Of NIDA Grant Funding For Development Of A Nalmefene Implant PR Newswire (US) - 9/18/2019 8:00:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 9/12/2019 9:29:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2019 11:36:37 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 8/19/2019 5:27:56 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2019 4:13:56 PM
Titan Pharmaceuticals Reports Second Quarter 2019 Financial Results PR Newswire (US) - 8/14/2019 4:03:00 PM
Titan Pharmaceuticals To Release Second Quarter 2019 Financial Results On August 14 - Conference Call To Follow PR Newswire (US) - 8/9/2019 5:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/8/2019 5:30:20 PM
Zilla   Wednesday, 10/16/19 10:20:18 PM
Re: Jkings post# 14907
Post # of 15046 
I actually just bought back in from when I sold over a buck and before the 1 for 6 RS. I expect another RS but to spend 800 for more than what I sold for around 22,000 was just me 'gambling' to see if this ever gets footing. I expect to double down after a 50% haircut after an RS but at least I know what I'm getting into. A POS 100% agreed and yet I'm in...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist